Health Minister launches high drug price consultations

CBC News

16 May 2017 - Canadian drug spending has ballooned by 184% since 2000 as a share of gross domestic product.

Health Minister Jane Philpott is announcing consultations on a suite of proposed regulatory changes related to the Patented Medicine Prices Review Board.

Philpott says the board was created 30 years ago to protect consumers and to ensure companies do not use monopolies to charge excessive costs.

She says, however, the board is limited in its ability to protect consumers from high drug prices, a problem the federal government wants to address.

Read CBC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Review , Pricing , Canada